GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Operating Cash Flow per Share

Aarti Drugs (BOM:524348) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Operating Cash Flow per Share?

Aarti Drugs's operating cash flow per share for the three months ended in Mar. 2024 was ₹0.00. Aarti Drugs's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Aarti Drugs was 171.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 32.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.10% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Aarti Drugs's Operating Cash Flow per Share or its related term are showing as below:

BOM:524348' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -20.6   Med: 13.7   Max: 49.8
Current: 32.9

During the past 13 years, Aarti Drugs's highest 3-Year average Operating Cash Flow per Share Growth Rate was 49.80% per year. The lowest was -20.60% per year. And the median was 13.70% per year.

BOM:524348's 3-Year OCF Growth Rate is ranked better than
79.03% of 806 companies
in the Drug Manufacturers industry
Industry Median: 7.45 vs BOM:524348: 32.90

Aarti Drugs Operating Cash Flow per Share Historical Data

The historical data trend for Aarti Drugs's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Operating Cash Flow per Share Chart

Aarti Drugs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.90 16.63 7.60 14.40 39.04

Aarti Drugs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aarti Drugs's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aarti Drugs's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Price-to-Operating-Cash-Flow falls into.



Aarti Drugs Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Aarti Drugs's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )=Cash Flow from Operations (A: Mar. 2024 )/Shares Outstanding (Diluted Average) (A: Mar. 2024 )
=3589.2/91.940
=39.04

Aarti Drugs's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=0/91.935
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aarti Drugs Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aarti Drugs (BOM:524348) Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400 022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs) in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm generates the majority of its revenue from India.

Aarti Drugs (BOM:524348) Headlines

No Headlines